Yatırımcı.AI

TRILC vs ORMA Comparison

Price, market cap, valuation, profitability and leverage metrics of TRILC and ORMA side by side.

TRILCORMA
StockFund

If you had invested TRY 10,000

Metric comparison

TRILC vs ORMA Comparison
MetricTRILCORMASector median
Last price (TL)0.91148.0018.72
Daily change1.11%0.00%−4.75%
Market capTRY 943.7MTRY 4BTRY 4.4B
P/E—174.2318.20
P/B0.470.501.14
Return on equity−4.59%0.28%1.78%
Free float73.16%13.36%37.21%
Ratios are calculated from the latest published financial statements.

Popular comparisons

Related pages

About the TRILC vs ORMA comparison

Price, market cap, valuation multiples, profitability and leverage of TRILC (Türk İlaç Serum) and ORMA (Orma Orman Mahsulleri) side by side as of Sep 28, 2026, 10:00. Of the 15 metrics compared, TRILC leads in 8 and ORMA leads in 7.

Highlights: Daily change: TRILC leads (1.11% vs 0.00%). Market cap: ORMA leads (TRY 4B vs TRY 943.7M). P/B: TRILC leads (0.47 vs 0.50). EV/EBITDA: TRILC leads (3.67 vs 14.48). EV/Sales: ORMA leads (2.75 vs 3.61). Gross margin: TRILC leads (25.29% vs 17.54%). EBITDA margin (annual): TRILC leads (27.80% vs 12.02%). Net margin (annual): ORMA leads (0.52% vs −1.65%).

Frequently asked questions

By P/E, Tie is cheaper (— vs 174.23); by P/B, TRILC trades at the lower multiple (0.47 vs 0.50).

Annual net margin is −1.65% for TRILC and 0.52% for ORMA; return on equity is −4.59% for TRILC and 0.28% for ORMA.

The leverage ratio is 76.53 for TRILC and 38.01 for ORMA; net debt/EBITDA is 2.88 for TRILC and 5.92 for ORMA. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.